Ibilex is a medicine containing the active ingredient(s) cefalexin. On this page you will find out more about Ibilex, including side effects, age restrictions, food interactions and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS)
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional. Always read the label. If symptoms persist see your healthcare professional. healthdirect medicines information is not intended for use in an emergency. If you are suffering an acute illness, overdose, or emergency condition, call triple zero (000) and ask for an ambulance.
Reasonable care has been taken to provide accurate information at the time of creation. This information is not intended to substitute medical advice, diagnosis or treatment and should not be exclusively relied on to manage or diagnose a medical condition. Please refer to our terms and conditions.
Active ingredient in this medicine: cefalexin
Pack size information
Please select the pack size from the options directly below to view information on the medicine.
Information for medicine and pack size:
Ibilex 250 mg hard capsule, 20
Consumer Medicine Information leaflet:
This leaflet may also be found inside the medicine package. It contains information on side effects, age restrictions and other useful data.
What this medicine is for
INDICATIONS AS AT 24 FEBRUARY 2004: IBILEX is indicated in the treatment of the following infections when caused by susceptible strains of the designated microorganisms: Respiratory tract infections caused by S. pneumoniae and group A beta-haemolytic streptococci (Penicillin is the usual drug of choice in the treatment and prevention of streptococcal infections, including the prophylaxis of rheumatic fever. IBILEX is generally effective in the eradication of streptococci from nasopharynx; however, substantial data establishing the efficacy of IBILEX in the subsequent prevention of rheumatic fever are not available at present.) Bacterial sinusitis caused by streptococci, S. pneumoniae and S. aureus (methicillin-sensitive only) Otitis media due to S. pneumoniae, staphylococci; Skin and soft tissue infections caused by staphlococci anr/or streptococci; Genitourinary tract infections, including acute prostatic caused by E. coli, P. mirabilis, and Klebsiella sp. The effectiveness of IBILEX in the treatment of bacterial infections of the brain and spinal column has not been established and IBILEX is not indicated in these conditions. NOTE: Appropriate culture and susceptibility test should be initiated prior to and during therapy to determine susceptibility of the causative organism to IBILEX. Renal function studies should be performed when indicated
Table of characteristics
An opaque green and white capsule, size 1.
Images are the copyright of the Pharmacy Guild of Australia
|Dosage Form||Capsule, hard|
|Route of administration||Oral|
20: Prescription Only Medicine, or Prescription Animal Remedy
There is one type of pack available.
Pack type 1
|Storage temperature||Store below 30 degrees Celsius|
|Storage conditions||No information available|
|Life time||3 Years|
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on 1 February 2018
The PBS provides a list of government subsidised medicines available to be dispensed to patients. Further information can be found on the Pharmaceutical Benefits Scheme website.
Is this medication banned in sport?
Check if you can use your medicine whilst playing sport. Search the Australian Sports Anti-Doping Authority (ASADA) database that provides information about the prohibited status of specific medications and/or the active ingredient based on the current World Anti-Doping Agency (WADA) Prohibited List.